Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is aiming to expand the breadth of its spinal offerings and, in particular, reach a relatively untapped older patient population with its $3.9 billion acquisition of Kyphon, announced July 27 (see chart: "1Medtronic-Kyphon Deal Basics")